Q-Med, a medical device company, has obtained Chinese registration approval for Restylane, a dermal filler designed to smooth away wrinkles and folds.
Subscribe to our email newsletter
According to the company, an application for sales approval will be submitted shortly and the sales of the product will begin at the end of the second quarter in 2009.
Bengt Agerup, president and CEO of Q-Med, said: “There is a large appetite for new things in China and great respect for products from the West. We are therefore very pleased about this registration approval, which means that Restylane will be the first hyaluronic acid product intended for the cosmetic market in China.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.